|
|
IDENTIFICATION OF OPTIMUM SPECTACLE PRESCRIPTIONS FOR PATIENTS WITH DOWN SYNDROME |
| 3R01EY024590-05S1 |
ANDERSON, HEATHER ANNE |
NEI |
2018 |
|
|
MECHANISMS OF ASSEMBLY OF PHOTORECEPTOR G PROTEIN COMPLEXES |
| 5R01EY012287-16 |
WILLARDSON, BARRY M |
NEI |
2018 |
|
|
IDENTIFICATION OF OPTIMUM SPECTACLE PRESCRIPTIONS FOR PATIENTS WITH DOWN SYNDROME |
| 5R01EY024590-05 |
ANDERSON, HEATHER ANNE |
NEI |
2018 |
|
|
RETINAL VERSUS CORTICAL CONTRIBUTIONS TO VISION LOSS IN ALBINISM |
| 5R01EY024969-04 |
CARROLL, JOSEPH |
NEI |
2018 |
|
|
MECHANISMS OF SYNAPTIC SPECIFICITY IN VISUAL CIRCUITS |
| 5R01EY025627-04 |
TRIPLETT, JASON |
NEI |
2018 |
|
|
ACTIVATION OF THE ANGIOPOIETIN-TIE2 PATHWAY TO TREAT OCULAR HYPERTENSION AND GLAUCOMA |
| 5R01EY025799-03 |
QUAGGIN, SUSAN E. |
NEI |
2018 |
|
|
RAPALOG THERAPY IN HERITABLE AND VIGABATRIN-INDUCED GABA METABOLIC DISORDERS |
| 5R01EY027476-02 |
GIBSON, K MICHAEL |
NEI |
2018 |
|
|
INFANT APHAKIA TREATMENT STUDY-CHAIRMAN'S GRANT |
| 5UG1EY013272-17 |
LAMBERT, SCOTT R |
NEI |
2018 |
|
|
COORDINATING CENTER FOR INFANT APHAKIA TREATMENT STUDY (IATS) |
| 5UG1EY013287-16 |
NIZAM, AZHAR |
NEI |
2018 |
|
|
INFANT APHAKIA TREATMENT STUDY-CLINICAL CENTERS |
| 5UG1EY025553-04 |
DREWS-BOTSCH, CAROLYN DAWSON |
NEI |
2018 |
